CML is a myeloproliferative neoplasm caused by the BCR‑ABL fusion (t(9;22)) that drives uncontrolled myeloid proliferation. Key points: low LAP vs leukemoid reaction, basophilia, splenomegaly, and confirmation by BCR‑...
Open this topic in Core Concepts